A Phase 2, Randomized Study to Assess the Safety and Ant

  • Green, Jaime S (PI)

Project: Research project

Project Details

Description

A Phase 2, Randomized Study to Assess the Safety and Anti-Cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections that are Resistant or Refractory to Treatment with Ganciclovir/Valganciclovir or Foscarnet in Transpl
StatusFinished
Effective start/end date8/1/127/31/15

Funding

  • ViroPharma Incorporated

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.